Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia (Q35659879)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 November 2014

Language	Label	Description	Also known as
English	Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia	scientific article published on 19 November 2014

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

9 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

2

object named as

Hagop M Kantarjian

1 reference

Europe PubMed Central

9 August 2017

5

object named as

Zeev Estrov

1 reference

Europe PubMed Central

9 August 2017

Jorge Eduardo Cortes

15

object named as

Jorge Cortes

1 reference

Europe PubMed Central

9 August 2017

4

object named as

Susan O'Brien

1 reference

Europe PubMed Central

9 August 2017

6

object named as

Farhad Ravandi

1 reference

Europe PubMed Central

9 August 2017

7

object named as

Elias Jabbour

1 reference

Europe PubMed Central

9 August 2017

Gautam Borthakur

16

object named as

Gautam Borthakur

1 reference

Europe PubMed Central

9 August 2017

12

object named as

Sherry Pierce

1 reference

Europe PubMed Central

9 August 2017

Guillermo Garcia-Manero

14

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

9 August 2017

Naveen Pemmaraju

8

object named as

Naveen Pemmaraju

1 reference

Europe PubMed Central

9 August 2017

1

object named as

Tapan M Kadia

1 reference

Europe PubMed Central

9 August 2017

9

object named as

Naval Daver

1 reference

Europe PubMed Central

9 August 2017

13

object named as

Mark Brandt

1 reference

Europe PubMed Central

9 August 2017

11

object named as

Preetesh Jain

1 reference

Europe PubMed Central

9 August 2017

author name string

Deborah A Thomas

3

1 reference

Europe PubMed Central

9 August 2017

Xuemei Wang

10

1 reference

Europe PubMed Central

9 August 2017

publication date

19 November 2014

1 reference

Europe PubMed Central

9 August 2017

American Journal of Hematology

1 reference

Europe PubMed Central

9 August 2017

90

1 reference

Europe PubMed Central

9 August 2017

120-124

1 reference

Europe PubMed Central

9 August 2017

2

1 reference

Europe PubMed Central

9 August 2017

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Asparaginase revisited

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Peg-asparaginase for acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Adult acute lymphoblastic leukemia: concepts and strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

12 July 2018

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Outcome of adults with acute lymphocytic leukemia after second salvage therapy

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

New statistical strategy for monitoring safety and efficacy in single-arm clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthracycline containing regimen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

25 September 2018

Asparaginase-methotrexate in combination chemotherapy: schedule-dependent differential effects on normal versus neoplastic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

25 September 2018

L-asparaginase-induced modulation of methotrexate polyglutamylation in murine leukemia L5178Y.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4447180

25 September 2018

Acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23886

21 January 2018

Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25368968

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/AJH.23886

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35659879&oldid=2108629292"